Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 2022-05, Vol.126 (9), p.1362-1362 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1362 |
|---|---|
| container_issue | 9 |
| container_start_page | 1362 |
| container_title | British journal of cancer |
| container_volume | 126 |
| creator | van Breeschoten, Jesper Wouters, Michel W. J. M. Hilarius, Doranne L. Haanen, John B. Blank, Christian U. Aarts, Maureen J. B. van den Berkmortel, Franchette W. P. J. de Groot, Jan-Willem B. Hospers, Geke A. P. Kapiteijn, Ellen Piersma, Djura van Rijn, Roos S. Suijkerbuijk, Karijn P. M. Blokx, Willeke A. M. Tije, Bert-Jan J. ten Veldt, Astrid A. M. van der Vreugdenhil, Art Boers-Sonderen, Marye J. van den Eertwegh, Alfonsus J. M. |
| description | |
| doi_str_mv | 10.1038/s41416-022-01772-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9043178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2655325430</sourcerecordid><originalsourceid>FETCH-LOGICAL-c247z-c48b4fa7473ef28b61d785196eb8e18d529dd3540edf715f1702bfb1f95ca1dd3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EokPhBVhZYsPG1L-x0wVSGTqAKAIhYGs5idNxldip7USaeZe-a91OBYIFK1_rfufce3UAeEnwG4KZOkmccFIhTCnCREqK9o_AighGEVFUPgYrjLFEuKb4CDxL6ap8a6zkU3DEBBWVFNUK3KxDjLbNLvhTuHExZTQ4b-G772ebky_nn6HzW9e4HGKCi41pTtD47NC394jAMfiQtzaaaVe4e82vCmM0zrlA0HSL8a3t4GgH48No4GSysz6nU1jqGCbrk8s7NJrcbguX5ri4xQxlhBl2yaXn4ElvhmRfPLzH4Ofm_Mf6I7r4-uHT-uwCtZTLPWq5anhvJJfM9lQ1FemkEqSubKMsUZ2gddcxwbHteklETySmTd-QvhatIaV1DN4efKe5GW3Xlh2jGfQU3WjiTgfj9N8d77b6Miy6xpwRqYrB6weDGK5nm7IeXWrtUO62YU6aVkwyIhShBX31D3oV5lgOvqNESU9whgtFD1QbQ0rR9r-XIVjfpa8P6euSvr5PX--LiB1EqcD-0sY_1v9R3QIYv7Qx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655325430</pqid></control><display><type>article</type><title>Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis</title><source>Springer Journals</source><source>Free E-Journal (出版社公開部分のみ）</source><source>PubMed Central</source><creator>van Breeschoten, Jesper ; Wouters, Michel W. J. M. ; Hilarius, Doranne L. ; Haanen, John B. ; Blank, Christian U. ; Aarts, Maureen J. B. ; van den Berkmortel, Franchette W. P. J. ; de Groot, Jan-Willem B. ; Hospers, Geke A. P. ; Kapiteijn, Ellen ; Piersma, Djura ; van Rijn, Roos S. ; Suijkerbuijk, Karijn P. M. ; Blokx, Willeke A. M. ; Tije, Bert-Jan J. ten ; Veldt, Astrid A. M. van der ; Vreugdenhil, Art ; Boers-Sonderen, Marye J. ; van den Eertwegh, Alfonsus J. M.</creator><creatorcontrib>van Breeschoten, Jesper ; Wouters, Michel W. J. M. ; Hilarius, Doranne L. ; Haanen, John B. ; Blank, Christian U. ; Aarts, Maureen J. B. ; van den Berkmortel, Franchette W. P. J. ; de Groot, Jan-Willem B. ; Hospers, Geke A. P. ; Kapiteijn, Ellen ; Piersma, Djura ; van Rijn, Roos S. ; Suijkerbuijk, Karijn P. M. ; Blokx, Willeke A. M. ; Tije, Bert-Jan J. ten ; Veldt, Astrid A. M. van der ; Vreugdenhil, Art ; Boers-Sonderen, Marye J. ; van den Eertwegh, Alfonsus J. M.</creatorcontrib><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/s41416-022-01772-z</identifier><identifier>PMID: 35256756</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1813/1634 ; 692/4028/67/1813/1634 ; 692/699/67/1813/1634 ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Correction ; Drug Resistance ; Epidemiology ; Molecular Medicine ; Oncology</subject><ispartof>British journal of cancer, 2022-05, Vol.126 (9), p.1362-1362</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-0446-1907</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043178/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043178/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids></links><search><creatorcontrib>van Breeschoten, Jesper</creatorcontrib><creatorcontrib>Wouters, Michel W. J. M.</creatorcontrib><creatorcontrib>Hilarius, Doranne L.</creatorcontrib><creatorcontrib>Haanen, John B.</creatorcontrib><creatorcontrib>Blank, Christian U.</creatorcontrib><creatorcontrib>Aarts, Maureen J. B.</creatorcontrib><creatorcontrib>van den Berkmortel, Franchette W. P. J.</creatorcontrib><creatorcontrib>de Groot, Jan-Willem B.</creatorcontrib><creatorcontrib>Hospers, Geke A. P.</creatorcontrib><creatorcontrib>Kapiteijn, Ellen</creatorcontrib><creatorcontrib>Piersma, Djura</creatorcontrib><creatorcontrib>van Rijn, Roos S.</creatorcontrib><creatorcontrib>Suijkerbuijk, Karijn P. M.</creatorcontrib><creatorcontrib>Blokx, Willeke A. M.</creatorcontrib><creatorcontrib>Tije, Bert-Jan J. ten</creatorcontrib><creatorcontrib>Veldt, Astrid A. M. van der</creatorcontrib><creatorcontrib>Vreugdenhil, Art</creatorcontrib><creatorcontrib>Boers-Sonderen, Marye J.</creatorcontrib><creatorcontrib>van den Eertwegh, Alfonsus J. M.</creatorcontrib><title>Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><subject>631/67/1813/1634</subject><subject>692/4028/67/1813/1634</subject><subject>692/699/67/1813/1634</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Correction</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kc1u1DAUhS0EokPhBVhZYsPG1L-x0wVSGTqAKAIhYGs5idNxldip7USaeZe-a91OBYIFK1_rfufce3UAeEnwG4KZOkmccFIhTCnCREqK9o_AighGEVFUPgYrjLFEuKb4CDxL6ap8a6zkU3DEBBWVFNUK3KxDjLbNLvhTuHExZTQ4b-G772ebky_nn6HzW9e4HGKCi41pTtD47NC394jAMfiQtzaaaVe4e82vCmM0zrlA0HSL8a3t4GgH48No4GSysz6nU1jqGCbrk8s7NJrcbguX5ri4xQxlhBl2yaXn4ElvhmRfPLzH4Ofm_Mf6I7r4-uHT-uwCtZTLPWq5anhvJJfM9lQ1FemkEqSubKMsUZ2gddcxwbHteklETySmTd-QvhatIaV1DN4efKe5GW3Xlh2jGfQU3WjiTgfj9N8d77b6Miy6xpwRqYrB6weDGK5nm7IeXWrtUO62YU6aVkwyIhShBX31D3oV5lgOvqNESU9whgtFD1QbQ0rR9r-XIVjfpa8P6euSvr5PX--LiB1EqcD-0sY_1v9R3QIYv7Qx</recordid><startdate>20220518</startdate><enddate>20220518</enddate><creator>van Breeschoten, Jesper</creator><creator>Wouters, Michel W. J. M.</creator><creator>Hilarius, Doranne L.</creator><creator>Haanen, John B.</creator><creator>Blank, Christian U.</creator><creator>Aarts, Maureen J. B.</creator><creator>van den Berkmortel, Franchette W. P. J.</creator><creator>de Groot, Jan-Willem B.</creator><creator>Hospers, Geke A. P.</creator><creator>Kapiteijn, Ellen</creator><creator>Piersma, Djura</creator><creator>van Rijn, Roos S.</creator><creator>Suijkerbuijk, Karijn P. M.</creator><creator>Blokx, Willeke A. M.</creator><creator>Tije, Bert-Jan J. ten</creator><creator>Veldt, Astrid A. M. van der</creator><creator>Vreugdenhil, Art</creator><creator>Boers-Sonderen, Marye J.</creator><creator>van den Eertwegh, Alfonsus J. M.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0446-1907</orcidid></search><sort><creationdate>20220518</creationdate><title>Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis</title><author>van Breeschoten, Jesper ; Wouters, Michel W. J. M. ; Hilarius, Doranne L. ; Haanen, John B. ; Blank, Christian U. ; Aarts, Maureen J. B. ; van den Berkmortel, Franchette W. P. J. ; de Groot, Jan-Willem B. ; Hospers, Geke A. P. ; Kapiteijn, Ellen ; Piersma, Djura ; van Rijn, Roos S. ; Suijkerbuijk, Karijn P. M. ; Blokx, Willeke A. M. ; Tije, Bert-Jan J. ten ; Veldt, Astrid A. M. van der ; Vreugdenhil, Art ; Boers-Sonderen, Marye J. ; van den Eertwegh, Alfonsus J. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c247z-c48b4fa7473ef28b61d785196eb8e18d529dd3540edf715f1702bfb1f95ca1dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>631/67/1813/1634</topic><topic>692/4028/67/1813/1634</topic><topic>692/699/67/1813/1634</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Correction</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Breeschoten, Jesper</creatorcontrib><creatorcontrib>Wouters, Michel W. J. M.</creatorcontrib><creatorcontrib>Hilarius, Doranne L.</creatorcontrib><creatorcontrib>Haanen, John B.</creatorcontrib><creatorcontrib>Blank, Christian U.</creatorcontrib><creatorcontrib>Aarts, Maureen J. B.</creatorcontrib><creatorcontrib>van den Berkmortel, Franchette W. P. J.</creatorcontrib><creatorcontrib>de Groot, Jan-Willem B.</creatorcontrib><creatorcontrib>Hospers, Geke A. P.</creatorcontrib><creatorcontrib>Kapiteijn, Ellen</creatorcontrib><creatorcontrib>Piersma, Djura</creatorcontrib><creatorcontrib>van Rijn, Roos S.</creatorcontrib><creatorcontrib>Suijkerbuijk, Karijn P. M.</creatorcontrib><creatorcontrib>Blokx, Willeke A. M.</creatorcontrib><creatorcontrib>Tije, Bert-Jan J. ten</creatorcontrib><creatorcontrib>Veldt, Astrid A. M. van der</creatorcontrib><creatorcontrib>Vreugdenhil, Art</creatorcontrib><creatorcontrib>Boers-Sonderen, Marye J.</creatorcontrib><creatorcontrib>van den Eertwegh, Alfonsus J. M.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Breeschoten, Jesper</au><au>Wouters, Michel W. J. M.</au><au>Hilarius, Doranne L.</au><au>Haanen, John B.</au><au>Blank, Christian U.</au><au>Aarts, Maureen J. B.</au><au>van den Berkmortel, Franchette W. P. J.</au><au>de Groot, Jan-Willem B.</au><au>Hospers, Geke A. P.</au><au>Kapiteijn, Ellen</au><au>Piersma, Djura</au><au>van Rijn, Roos S.</au><au>Suijkerbuijk, Karijn P. M.</au><au>Blokx, Willeke A. M.</au><au>Tije, Bert-Jan J. ten</au><au>Veldt, Astrid A. M. van der</au><au>Vreugdenhil, Art</au><au>Boers-Sonderen, Marye J.</au><au>van den Eertwegh, Alfonsus J. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><date>2022-05-18</date><risdate>2022</risdate><volume>126</volume><issue>9</issue><spage>1362</spage><epage>1362</epage><pages>1362-1362</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35256756</pmid><doi>10.1038/s41416-022-01772-z</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0446-1907</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 2022-05, Vol.126 (9), p.1362-1362 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9043178 |
| source | Springer Journals; Free E-Journal (出版社公開部分のみ）; PubMed Central |
| subjects | 631/67/1813/1634 692/4028/67/1813/1634 692/699/67/1813/1634 Biomedical and Life Sciences Biomedicine Cancer Research Correction Drug Resistance Epidemiology Molecular Medicine Oncology |
| title | Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A08%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20First-line%20BRAF/MEK%20inhibitors%20versus%20anti-PD-1%20monotherapy%20in%20BRAFV600-mutant%20advanced%20melanoma%20patients:%20a%20propensity-matched%20survival%20analysis&rft.jtitle=British%20journal%20of%20cancer&rft.au=van%20Breeschoten,%20Jesper&rft.date=2022-05-18&rft.volume=126&rft.issue=9&rft.spage=1362&rft.epage=1362&rft.pages=1362-1362&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/s41416-022-01772-z&rft_dat=%3Cproquest_pubme%3E2655325430%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655325430&rft_id=info:pmid/35256756&rfr_iscdi=true |